Quintiles Transnational Holdings Inc. (NYSE: Q) has seen its so-called analyst quiet period come to an end. The company’s IPO was close to $950 million, which had been an upsized offering at $40.00 per share. The trading has been positive as the price of Quintiles stock has never been back down at the IPO price. The new analyst coverage is mostly positive, with a couple of less optimistic valuation calls in the mix.
Shares closed at $43.53 on Monday and have traded in a post-IPO range of $41.78 to $46.50. Yahoo! Finance lists its market cap as $5.04 billion, and the stock has traded an average of almost 1.5 million shares per day.
Here are the analyst rating initiations seen so far for the biopharmaceutical development services and commercial outsourcing company:
- Started as Hold at Jefferies
- Started as Neutral at Goldman
- Started as Buy at Deutsche Bank
- Started as Overweight at J.P. Morgan
- Started as Overweight at Morgan Stanley
- Started as Overweight at Piper Jaffray
- Started as Outperform at Raymond James
- Started as Outperform at Wells Fargo
Note that Sterne Agee initiated coverage on this last week, ahead of the underwriting syndicate, and it only assigned an Underperform rating.
And note that while the average daily volume is high at 1.5 million shares, that figure includes the first few trading days. It has been more than 20 trading sessions since the stock has actually traded 1 million shares.